Date of publication: December 19,
2006
Source:
http://gmoinfo.jrc.it/gmp_browse_geninf.asp
Notification number:
B/FR/06/12/10
Member State
France
Date of Acknowledgement
10/11/2006 00:00:00
Title of the Project
One year field trials programme (2007)
for the deliberate release of MON 88017 maize protected against
certain coleopteran insect pests (Diabrotica spp) and tolerant
to glyphosate
Proposed period of release:
01/04/2007 00:00:00 to 31/12/2007
00:00:00
Name of the Institute(s) or
Company(ies)
Monsanto Agriculture France S.A.S, ;
3. Is the same GMPt release planned
elsewhere in the Community?
Yes:
Has the same GMPt been notified
elsewhere by the same notifier?
Yes
If yes, notification number(s):
B/DE/05/169; B/ES/06/02; B/FR/05/04/01;
B/FR/06/01/02;
Other notifications
In addition, many field trials have
already been conducted across maize growing regions in North and
South America and other world area.
Genetically modified plant
Complete name of the recipient or
parental plant(s)
|
Common Name |
Family Name |
Genus |
Species |
Subspecies |
Cultivar/breeding line |
| maize |
poaceae |
zea |
zea mays |
mays |
A x Hi-II |
2. Description of the traits and
characteristics which have been introduced or modified,
including marker genes and previous modifications:
MON 88017 that will be tested in these
field trials is protected against certain coleopteran insect
pests (Diabrotica spp) and is tolerant to glyphosate herbicide.
Genetic modification
3. Type of genetic modification:
Insertion;
In case of insertion of genetic
material, give the source and intended function of each
constituent fragment of the region to be inserted:
MON 88017 contains the following
genetic elements :
- the cry3Bb1 gene from Bacillus thuringiensis subsp.
kumamotoensis which confers protection against certain
coleopteran pests (Diabrotica spp)
- the cp4 epsps gene from Agrobacterium sp. strain CP4, which
provides tolerance to ghyphosate herbicide.
These genes have been introduced with regulatory elements
necessary for expression in plant cells.
6. Brief description of the method
used for the genetic modification:
MON 88017 was produced by
Agrobacterium-mediated transformation of immature embryos of
maize tissue.
7. If the recipient or parental plant
is a forest tree species, describe ways and extent of
dissemination and specific factors affecting dissemination:
Not applicable
Experimental Release
1. Purpose of the release:
The aims of the release are:
1. to characterize MON 88017 maize under European crop
conditions, including analysis for protein expression.
2. to evaluate the agronomic performance and equivalence of MON
88017 to conventional maize.
3. to evaluate residues after applications with herbicide
formulations based on glyphosate.
2. Geographical location of the site:
The release is planned at several
locations in 2007 (Rhône-Alpes, Midi-Pyrénées, Aquitaine,
Poitou-Charentes, Centre, Lorraine).
The trial locations for the campaign 2007 are shown in the table
below:
Valvidienne (86)
Civaux (86)
Beux (57)
Allamont (54)
Moulotte (55)
Foameix-Ornel (55)
Yermenonville (28)
Poinville (28)
St Maurice de Gourdans (01)
Faramans (01)
Bourgoin-Jallieu (38)
Linxe (40)
Magescq (40)
Layrac (47)
Fronton (31)
Mauroux (32)
Serignac (82)
La Salvetat de Belmontet (82)
Monclar de Quercy (82)
3. Size of the site (m2):
Each site will have a maximum of 5 000
m² sown with MON 88017 concerned by this application, the total
area covered by the trial will be higher.
4. Relevant data regarding previous
releases carried out with the same GM-plant, if any,
specifically related to the potential environmental and human
health impacts from the release:
Many field trials have already been
conducted at several locations across maize growing regions in
North and South America. No environmental problems were reported
for these trials. Except for its protection against certain
coleopteran insects and its tolerance to glyphosate herbicide,
MON 88017 could not be distinguished from conventional maize.
Insect-protection and glyphosate tolerance traits present in MON
88017 are present, alone or in combination, in commercial
products, NK603, MON 863 and MON 863 x NK603, which have a
safety commercial experience.
Environmental Impact and Risk
Management
Summary of the potential environmental
impact from the release of the GMPts:
Analysis of the characteristics of MON
88017 maize, especially in comparison with extensive experience
with cultivation of conventional maize within the E.U., has
shown that the risk for potential adverse effects on human and
animal health and the receiving environment, resulting from the
planned field trials with MON 88017 maize, is negligible:
· The risk of the introduced traits in MON 88017 maize to be the
cause of any meaningful competitive advantage or disadvantage in
natural environments is negligible. As for any other maize, the
likelihood of this maize to spread into non-agronomic
environments is negligible, as its persistence in agricultural
habitats and its invasiveness into natural habitats are
unaltered compared to conventional maize.
· Potential exposure of non-target organisms to CP4 EPSPS
presents no conceivable mechanism to cause adverse effects
because of its properties. Due to the selectivity of Cry3Bb1
protein to certain coleopteran insects and based on studies with
different species, the risk for non target organisms is
considered negligible. The ecological interactions of MON 88017
maize with non target organisms or soil process are considered
similar to the respective caused by conventional corn
· Any occupational health aspects of handling MON 88017 maize
are not different from conventional maize, and this maize was
shown to be as safe and as nutritious as any other maize.
· The environmental impact of the cultivation, management and
harvesting techniques applied in the planned trials is
considered no different from the farming practices for
conventional maize.
It is actually expected that the commercial production of MON
88017 maize will positively impact current agronomic practices
in maize and provide benefits to farmers and the environment.
The protection against D. virgifera would offer a new tool for
IPM and would reduce the reliance on chemical pesticides whereas
the use of glyphosate in maize would enable the farmer to take
advantage of the herbicide’s favorable environmental and safety
properties (see Annex I listing of glyphosate under Council
Directive 91/414/EEC) as well as facilitate adoption of
conservation tillage practice in corn production
Measures will be taken to avoid seed dissemination at harvest
and during transportation (see E.). Maize can hybridize with
teosinte but these plants are not present in Europe. The
possibility of hybridization with other maize plants will be
minimised by a spatial isolation distance of 400 meters form
other cultivated maize. Some trials (efficacy especially) could
be carried out without isolation. In this case, the trials will
be destroyed before the flowering stage of the crop. Four rows
of conventional maize (commercial hybrid) will surround all the
trials and act as pollen trap.
Brief description of any measures
taken for the management of risks:
1. In addition to the scheduled observations of phenotypic and
agronomic parameters that form the basis of the planned
research, the trial site will be checked regularly during the
period of the deliberate release for potentially occurring,
direct or indirect, adverse environmental effects. This will be
done by visual inspection of the status of the MON 88017 crop
and that of its receiving environment. In case any adverse
environmental effects, linked to the deliberate release of MON
88017, are observed during the period of release, these will be
reported immediately to the Competent Authority.
2. The spatial isolation distance (400 m) from other maize crops
and the four rows of conventional maize surrounding the trials
will prevent most of the possibility of hybridisation with other
maize plants. Some trials (efficacy especially) could be carried
out without isolation. In this case, the trials will be
destroyed before the flowering stage of the crop.
3. The equipment, especially the experimental drill and combine,
will be cleaned on the experimental site, thus preventing seed
dissemination.
4. After completion of harvest, the stalks will be chopped and
then incorporated into the soil. Any shattered seed will be
allowed to germinate. The resulting seedlings will be destroyed
by soil incorporation. Maize cobs will be harvested by
experimental-plot combine, or by hand.
5. Although regrouwth in the rotation crops is unlikely because
of poor winter survival, the site will be sown either with a
crop different from maize or with experimental maize that will
be destroyed and not used in any commercial, industrial or food
application. Volunteer plants will be controlled by the use of
routinely used commercial antimonocotyledonous herbicides in
this crop.
6. Seeds will be transported in sealed and labelled bags placed
in a rigid container.
Summary of foreseen field trial
studies focused to gain new data on environmental and human
health impact from the release:
Not applicable.
However, any unanticipated adverse effects on human health or
the environment would be reported immediately to the Competent
Authority.
Final report
-
European Commission administrative
information
Consent given by the Competent
Authority:
Not known |
